MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Dynavax Technologies Corporation Depreciation & Amortization 2011-2026 | DVAX
Annual Depreciation & Amortization Dynavax Technologies Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.63 M | 4.34 M | 3.81 M | 4.3 M | 4.27 M | 8.94 M | 3.62 M | 3.24 M | 2.26 M | 1.36 M | 1.4 M | 1.33 M | 1.21 M | 1.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.94 M | 1.21 M | 3.29 M |
Quarterly Depreciation & Amortization Dynavax Technologies Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 1.17 M | - | - | - | 1.12 M | - | - | - | 1.01 M | - | 2.98 M | - | 985 K | - | 3.28 M | - | 1.11 M | - | 3.17 M | 2.06 M | 1.01 M | - | 7.84 M | 3.2 M | 1.7 M | - | 2.51 M | 1.66 M | 823 K | - | 2.46 M | 1.67 M | 789 K | - | 1.57 M | 946 K | 402 K | - | 958 K | 634 K | 335 K | - | 1.02 M | 680 K | 339 K | - | 986 K | 646 K | 319 K | - | 898 K | 592 K | 292 K | - | 1.01 M | 704 K | 360 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.84 M | 292 K | 1.44 M |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M |  USA |
 |
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M |  Canada |
 |
Adverum Biotechnologies
ADVM
|
3.65 M | - | - | $ 86.2 M | USA |
 |
AgeX Therapeutics
AGE
|
131 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Aptorum Group Limited
APM
|
1.13 M | $ 0.81 | 1.28 % | $ 4.42 M |  China |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | China |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
416 K | $ 4.65 | 1.31 % | $ 392 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | USA |
 |
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
BioVie
BIVI
|
229 K | $ 1.25 | - | $ 1.85 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
96.4 M | $ 62.62 | -0.48 % | $ 11.9 B | USA |
 |
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | USA |
 |
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | USA |
 |
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | USA |
 |
Capricor Therapeutics
CAPR
|
1.07 M | $ 27.91 | 0.14 % | $ 747 M | USA |
 |
CASI Pharmaceuticals
CASI
|
468 K | $ 0.8 | 5.68 % | $ 109 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
Catalyst Biosciences
CBIO
|
1.07 M | $ 12.65 | 10.29 % | $ 833 M | USA |
 |
Axsome Therapeutics
AXSM
|
503 K | $ 169.95 | -2.75 % | $ 8.45 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M |  Israel |
 |
Atreca
BCEL
|
5.46 M | - | -11.76 % | $ 5.79 M | USA |
 |
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | USA |
 |
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
780 M | $ 195.13 | -0.62 % | $ 28.6 B | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | USA |
 |
Baudax Bio
BXRX
|
165 K | - | 0.59 % | $ 63 K | USA |
 |
Aptose Biosciences
APTO
|
32 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |
 |
Cellectar Biosciences
CLRB
|
192 K | $ 3.36 | 3.07 % | $ 41.1 M | USA |